Versant Side Fund Iv, L.p. - Net Worth and Insider Trading
Versant Side Fund Iv, L.p. Net Worth
The estimated net worth of Versant Side Fund Iv, L.p. is at least $203 Million dollars as of 2024-11-13. Versant Side Fund Iv, L.p. is the 10% Owner of CRISPR Therapeutics AG and owns about 4,004,248 shares of CRISPR Therapeutics AG (CRSP) stock worth over $203 Million. Details can be seen in Versant Side Fund Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Versant Side Fund Iv, L.p. has not made any transactions after 2018-04-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Versant Side Fund Iv, L.p.
Versant Side Fund Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Versant Side Fund Iv, L.p. owns 7 companies in total, including IVERIC bio Inc (ISEE) , Inari Medical Inc (NARI) , and Oyster Point Pharma Inc (OYST) among others .
Click here to see the complete history of Versant Side Fund Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Versant Side Fund Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ISEE | IVERIC bio Inc | 2018-10-30 | 10 percent owner |
| NARI | Inari Medical Inc | 2020-11-17 | 10 percent owner |
| OYST | Oyster Point Pharma Inc | 2019-10-30 | 10 percent owner |
 | | 2018-04-23 | 10 percent owner |
| | 2016-07-19 | 10 percent owner |
| | 2011-11-15 | 10 percent owner |
| | 2022-04-29 | 10 percent owner |
Versant Side Fund Iv, L.p. Latest Holdings Summary
Versant Side Fund Iv, L.p. currently owns a total of 1 stock. Versant Side Fund Iv, L.p. owns 4,004,248 shares of CRISPR Therapeutics AG (CRSP) as of April 23, 2018, with a value of $203 Million.
Latest Holdings of Versant Side Fund Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2018-04-23 | 4,004,248 | 50.73 | 203,135,501 |
Holding Weightings of Versant Side Fund Iv, L.p.
Versant Side Fund Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Versant Side Fund Iv, L.p. has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 101,994 shares on April 23, 2018, which brought Versant Side Fund Iv, L.p. around $5 Million.
Insider Trading History of Versant Side Fund Iv, L.p.
- 1
Versant Side Fund Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Versant Side Fund Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Side Fund Iv, L.p. is 35.26%. GuruFocus also compares Versant Side Fund Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Side Fund Iv, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Versant Side Fund Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Versant Side Fund Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.04 | | | | | |
| Relative Return to S&P 500(%) | 35.56 | | | | | |
Versant Side Fund Iv, L.p. Ownership Network
Ownership Network List of Versant Side Fund Iv, L.p.
Ownership Network Relation of Versant Side Fund Iv, L.p.
Versant Side Fund Iv, L.p. Owned Company Details
What does IVERIC bio Inc do?
Who are the key executives at IVERIC bio Inc?
Versant Side Fund Iv, L.p. is the 10 percent owner of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .
IVERIC bio Inc (ISEE) Insider Trades Summary
Over the past 18 months, Versant Side Fund Iv, L.p. made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 40,000 shares made by Keith Westby ,
In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,000 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,000 shares.
IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.
IVERIC bio Inc Insider Transactions
Versant Side Fund Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Versant Side Fund Iv, L.p.. You might contact Versant Side Fund Iv, L.p. via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
